JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BSJP
6026
DELISTED
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
| $2K | ﹤0.01% |
69
| – | – |
2022 Q1
3 quarters
|
|
6027
FT Vest Buffered Allocation Defensive ETF
BUFT
$259M
| $2K | ﹤0.01% |
+100
| New | +$1.85K |
2022 Q4
0 quarters
|
|
6028
Global X MSCI China Consumer Discretionary ETF
CHIQ
$100M
| $2K | ﹤0.01% |
100
-22,272
| -100% | -$404K |
2022 Q2
2 quarters
|
|
6029
Curis
CRIS
$1.95M
| $2K | ﹤0.01% |
10
-5
| -33% | -$1.47K |
2021 Q2
6 quarters
|
|
6030
Invesco MSCI Global Timber ETF
CUT
$29M
| $2K | ﹤0.01% |
64
+9
| +16% | +$274 |
2021 Q1
7 quarters
|
|
6031
Dragonfly Energy
DFLI
$12.7M
| $2K | ﹤0.01% |
+2
| New | +$1.9K |
2022 Q4
0 quarters
|
|
6032
Direxion Daily FTSE Europe Bull 3x ETF
EURL
$39.4M
| $2K | ﹤0.01% |
+100
| New | +$1.5K |
2022 Q4
0 quarters
|
|
6033
iShares MSCI Netherlands ETF
EWN
$709M
| $2K | ﹤0.01% |
61
+28
| +85% | +$992 |
2021 Q2
6 quarters
|
|
6034
Fidelity D&D Bancorp
FDBC
$321M
| $2K | ﹤0.01% |
34
+32
| +1,600% | +$1.46K |
2018 Q2
18 quarters
|
|
6035
First Trust Emerging Markets AlphaDEX Fund
FEM
$813M
| $2K | ﹤0.01% |
+87
| New | +$1.74K |
2022 Q4
0 quarters
|
|
|
FINS
6036
Angel Oak Financial Strategies Income Term Trust
FINS
$400M
| $2K | ﹤0.01% |
+166
| New | +$2.15K |
2022 Q4
0 quarters
|
|
6037
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$283M
| $2K | ﹤0.01% |
+61
| New | +$2.29K |
2022 Q4
0 quarters
|
|
6038
CALL
Global E Online
GLBE
$6.6B
| $2K | ﹤0.01% |
100
| – | – |
2022 Q3
1 quarter
|
|
|
GLQ
6039
Clough Global Equity Fund
GLQ
$142M
| $2K | ﹤0.01% |
253
-2,049
| -89% | -$14.4K |
2022 Q3
1 quarter
|
|
|
VIP
6040
Vulcan Infrastructure and Power
VIP
$28M
| $2K | ﹤0.01% |
757
+71
| +10% | +$565 |
2021 Q3
5 quarters
|
|
|
GRX
6041
Gabelli Healthcare & Wellness Trust
GRX
$136M
| $2K | ﹤0.01% |
225
| – | – |
2015 Q4
28 quarters
|
|
6042
Xtrackers International Real Estate ETF
HAUZ
$988M
| $2K | ﹤0.01% |
+98
| New | +$2.01K |
2022 Q4
0 quarters
|
|
6043
Harvard Bioscience
HBIO
$38M
| $2K | ﹤0.01% |
86
-169
| -66% | -$4.17K |
2019 Q4
12 quarters
|
|
6044
Werewolf Therapeutics
HOWL
$45.1M
| $2K | ﹤0.01% |
748
-752
| -50% | -$1.97K |
2021 Q2
6 quarters
|
|
6045
Hyperfine
HYPR
$94.8M
| $2K | ﹤0.01% |
+2,581
| New | +$2.34K |
2022 Q4
0 quarters
|
|
6046
iShares MSCI Europe Small-Cap ETF
IEUS
$171M
| $2K | ﹤0.01% |
50
-575
| -92% | -$27K |
2021 Q3
5 quarters
|
|
|
IMA
6047
ImageneBio Inc
IMA
$52.2M
| $2K | ﹤0.01% |
73
-131
| -64% | -$4.19K |
2021 Q2
6 quarters
|
|
6048
Jaguar Health
JAGX
$1.9M
| – | – |
0
| – | – |
2021 Q4
4 quarters
|
|
6049
Korro Bio
KRRO
$142M
| $2K | ﹤0.01% |
11
-29
| -73% | -$2.98K |
2019 Q4
12 quarters
|
|
6050
Pasithea Therapeutics
KTTA
$15.9M
| $2K | ﹤0.01% |
150
+100
| +200% | +$2K |
2021 Q4
4 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.